Table 5.
Univariable | Multivariable | |||||
---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | |
Post-ECMO team period | 0.35 | 0.16–0.78 | 0.010 | 0.11 | 0.03–0.46 | 0.003 |
Asthma/COPD | 7.72 | 0.97–61.36 | 0.053 | 10.76 | 1.17–99.04 | 0.036 |
Malignancy | 2.76 | 1.12–6.78 | 0.027 | 3.97 | 1.21–13.01 | 0.023 |
Primary diagnosisa | – | – | – | – | – | – |
Viral pneumonia | 1.43 | 0.35–5.88 | 0.621 | 0.37 | 0.05–2.76 | 0.332 |
Others | 1.30 | 0.33–5.12 | 0.706 | 0.76 | 0.12–4.97 | 0.773 |
APACHE II score | 1.02 | 0.98–1.07 | 0.344 | 1.09 | 0.99–1.20 | 0.092 |
SOFA score | 1.02 | 0.93–1.12 | 0.654 | 1.10 | 0.91–1.32 | 0.314 |
RESP score | 0.85 | 0.73–0.99 | 0.034 | 0.77 | 0.62–0.96 | 0.020 |
PaO2/FiO2 prior to ECMO | 1.00 | 0.99–1.01 | 0.776 | 1.02 | 1.00–1.04 | 0.058 |
APACHE II acute physiology and chronic health evaluation II, COPD chronic obstructive pulmonary disease, ECMO extracorporeal membrane oxygenation, FiO2 fraction of inspired oxygen, MV mechanical ventilation, PaO2 partial pressure of oxygen in arterial blood, RESP respiratory extracorporeal membrane oxygenation survival prediction, SOFA sequential organ failure assessment
aThe reference group is bacterial pneumonia